3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Neoplasm Metastasis
3
Recurrence
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Prostatic Neoplasms
1
Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced Colorectal Cancer
1
Hodgkin Disease
1
HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
1
Gastric Adenocarcinoma
1
Colorectal Cancer Metastatic
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
1
Advanced Solid Tumor
1
Advanced Malignant Tumors
1
Advanced Gastric Cancer
1
Interventions
Trastuzumab
594
Paclitaxel
561
Cyclophosphamide
545
Docetaxel
478
Capecitabine
387
Letrozole
350
Fulvestrant
310
Doxorubicin
285
Carboplatin
277
Tamoxifen
257
Anastrozole
219
exemestane
211
Epirubicin
210
Radiotherapy
197
Bevacizumab
189
pertuzumab
175
Gemcitabine
163
Vinorelbine
162
pembrolizumab
161
Lapatinib
161
palbociclib
152
Exercise
132
Fluorouracil
118
Albumin-Bound Paclitaxel
116
eribulin
108
Magnetic Resonance Spectroscopy
108
130-nm albumin-bound paclitaxel
107
Everolimus
103
Taxes
96
Cisplatin
92
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Neoplasms
×
SHR-1701
×
Clear all
NCT04355858
2022-07-26
MULAN
Fudan University
Phase 2
Unknown
319 enrolled